CRGK

CareGen is a South Korean biotechnology company that specializes in the development and commercialization of biomimetic peptides and growth factors. The company operates across three primary sectors: cosmeceuticals, functional health foods, and pharmaceuticals. CareGen's core strength lies in its proprietary peptide library and synthesis technology, which allows for the creation of highly specific molecules for skin rejuvenation, hair growth, and metabolic health. Their flagship product, Deglusterol, is a peptide-based functional food ingredient designed to assist in blood sugar regulation. The company is vertically integrated, maintaining its own R&D and manufacturing facilities to support global distribution. CareGen is publicly traded on the KOSDAQ and continues to expand its therapeutic pipeline into areas like obesity and diabetes.